We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong Exhibits Brand-New All-in-One Molecular Diagnosis System at analytica Vietnam 2023

By LabMedica International staff writers
Posted on 19 Apr 2023
Print article
Image: The new Panall 8000 all-in-one molecular diagnosis system is being showcased at analytica Vietnam 2023 (Photo courtesy of Tianlong)
Image: The new Panall 8000 all-in-one molecular diagnosis system is being showcased at analytica Vietnam 2023 (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China), an innovative high-tech company specializing in molecular diagnostic products, is attending analytica Vietnam 2023, marking the first time Tianlong is exhibiting in Vietnam.

The 7th analytica Vietnam 2023 is taking place from April 19-21, 2023, at the Saigon Exhibition and Convention Center in Ho Chi Minh City, Vietnam. Recognized as the most crucial hub in the ASEAN Region, analytica Vietnam is celebrating its largest event to date, expecting 5,000 diagnostic professionals, top industry buyers, and investment decision-makers from over 30 countries worldwide.

At analytica Vietnam 2023, Tianlong is showcasing its brand-new all-in-one molecular diagnosis system Panall 8000, alongside its latest offerings in PCR laboratory diagnostics. Earlier, Tianlong had launched the Panall 8000 All-in-one Molecular Diagnosis System at Medlab Middle East 2023 where the new product had attracted significant attention.

The innovative lab booster, Tianlong Panall 8000, is a user-friendly and secure molecular diagnosis system that combines the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis. This system enables a truly seamless sample in-result out detection process and offers immense convenience for professionals through a one-key operation.

Alongside the Panall 8000, Tianlong is also presenting its innovative PCR lab solutions, including nucleic acid extractors, real-time PCR systems, sample processing systems, liquid handling systems, and compatible reagents, at analytica Vietnam 2023.

Related Links:
Tianlong Science and Technology

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.